» Articles » PMID: 34216635

Assessment of Effective Mitigation and Prediction of the Spread of SARS-CoV-2 in Germany Using Demographic Information and Spatial Resolution

Abstract

Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we include realistic prepandemic and recently recorded contact patterns between age groups. The implementation of non-pharmaceutical interventions will occur on changed contact patterns, improved isolation, or reduced infectiousness when, e.g., wearing masks. In order to account for spatial heterogeneity, we use a graph approach and we include high-quality information on commuting activities combined with traveling information from social networks. The remaining uncertainty will be accounted for by a large number of randomized simulation runs. Based on the derived factors for the effectiveness of different non-pharmaceutical interventions over the past months, we provide different forecast scenarios for the upcoming time.

Citing Articles

Hybrid metapopulation agent-based epidemiological models for efficient insight on the individual scale: A contribution to green computing.

Bicker J, Schmieding R, Meyer-Hermann M, Kuhn M Infect Dis Model. 2025; 10(2):571-590.

PMID: 39944375 PMC: 11815675. DOI: 10.1016/j.idm.2024.12.015.


Dynamic Contact Networks in Confined Spaces: Synthesizing Micro-Level Encounter Patterns through Human Mobility Models from Real-World Data.

Diallo D, Schonfeld J, Blanken T, Hecking T Entropy (Basel). 2024; 26(8).

PMID: 39202173 PMC: 11487436. DOI: 10.3390/e26080703.


Mass testing to end the COVID-19 public health threat.

Philippe C, Bar-Yam Y, Bilodeau S, Gershenson C, Raina S, Chiou S Lancet Reg Health Eur. 2023; 25:100574.

PMID: 36628300 PMC: 9816799. DOI: 10.1016/j.lanepe.2022.100574.


Characteristics of hospitalized patients with SARS-CoV-2 infection during successive waves of the COVID-19 pandemic in a reference hospital in Spain.

Iftimie S, Lopez-Azcona A, Lozano-Olmo M, Hernandez-Aguilera A, Sarra-Moreto S, Joven J Sci Rep. 2022; 12(1):17384.

PMID: 36253391 PMC: 9574827. DOI: 10.1038/s41598-022-22145-9.


Modelling airborne transmission of SARS-CoV-2 at a local scale.

Rahn S, Godel M, Koster G, Hofinger G PLoS One. 2022; 17(8):e0273820.

PMID: 36040921 PMC: 9426895. DOI: 10.1371/journal.pone.0273820.


References
1.
He D, Zhao S, Lin Q, Zhuang Z, Cao P, Wang M . The relative transmissibility of asymptomatic COVID-19 infections among close contacts. Int J Infect Dis. 2020; 94:145-147. PMC: 7166025. DOI: 10.1016/j.ijid.2020.04.034. View

2.
Buitrago-Garcia D, Egli-Gany D, Counotte M, Hossmann S, Imeri H, Ipekci A . Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020; 17(9):e1003346. PMC: 7508369. DOI: 10.1371/journal.pmed.1003346. View

3.
Jarvis C, van Zandvoort K, Gimma A, Prem K, Klepac P, James Rubin G . Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med. 2020; 18(1):124. PMC: 7202922. DOI: 10.1186/s12916-020-01597-8. View

4.
Buonanno G, Stabile L, Morawska L . Estimation of airborne viral emission: Quanta emission rate of SARS-CoV-2 for infection risk assessment. Environ Int. 2020; 141:105794. PMC: 7211635. DOI: 10.1016/j.envint.2020.105794. View

5.
Zhang J, Litvinova M, Liang Y, Wang Y, Wang W, Zhao S . Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science. 2020; 368(6498):1481-1486. PMC: 7199529. DOI: 10.1126/science.abb8001. View